Katerina Vavrova

Prof. Katerina Vavrova

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2020 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
AKAndrej Kováčik
Andrej Kováčik
MKMonika Kopečná
Monika Kopečná
KVKaterina Vavrova
Katerina Vavrova
Introduction: Transdermal drug delivery has several clinical benefits over conventional routes of drug administration. To open the transdermal route for a wider range of drugs, including macromolecules, numerous physical and chemical techniques to overcome the natural low skin permeability have been developed. Areas covered: This review focuses on permeation enhancers (penetration enhancers, percutaneous absorption promoters or accelerants), which are chemicals that increase drug flux through the skin barrier. First, skin components, drug permeation pathways, and drug properties are introduced. Next, we discuss properties of enhancers, their various classifications, structure-activity relationships, mechanisms of action, reversibility and toxicity, biodegradable enhancers, and synergistic enhancer combinations. Expert opinion: Overcoming the remarkable skin barrier properties in an efficient, temporary and safe manner remains a challenge. High permeation-enhancing potency has long been perceived to be associated with toxicity and irritation potential of such compounds, which has limited their further development. In addition, the complexity of enhancer interactions with skin, formulation and drug, along with their vast chemical diversity hampered understanding of their mechanisms of action. The recent development in the field revealed highly potent yet safe enhancers or enhancer combinations, which suggest that enhancer-aided transdermal drug delivery has yet to reach its full potential.

8 August 2012 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
JRJaroslav Roh
Jaroslav Roh
KVKaterina Vavrova
Katerina Vavrova
AHAlexandr Hrabálek
Alexandr Hrabálek

22 April 2015 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
MWMadeleine Witting
Madeleine Witting
ABAlexander Boreham
Alexander Boreham
RBRobert Brodwolf
Robert Brodwolf
KVKaterina Vavrova
Katerina Vavrova
UAUlrike Alexiev
Ulrike Alexiev
SHSarah Hedtrich
Sarah Hedtrich

6 December 2013 in Langmuir
Verified
Journal Article
Closed access
BŠBarbora Školová
Barbora Školová
BJBarbora Janůšová
Barbora Janůšová
Jarmila ZbytovskaJarmila Zbytovska
Jarmila Zbytovska
GGGert Gooris
Gert Gooris
JBJoke Bouwstra
Joke Bouwstra
KVKaterina Vavrova
Katerina Vavrova

1 March 2014 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KVKaterina Vavrova
Katerina Vavrova
DHDominika Henkes
Dominika Henkes
KSKay Strüver
Kay Strüver
MSMichaela Sochorová
Michaela Sochorová
BŠBarbora Školová
Barbora Školová
SHSarah Hedtrich
Sarah Hedtrich

15 March 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GKGalina Karabanovich
Galina Karabanovich
JZJúlia Zemanová
Júlia Zemanová
TSTomáš Smutný
Tomáš Smutný
RSRita Székely
Rita Székely
MŠMichal Šarkan
Michal Šarkan
JRJaroslav Roh
Jaroslav Roh